SCHEMBL128264

SCHEMBL128264

Oc1[c]cccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15637255 0.78 CA1 (0.39)
SCHEMBL3991 0.72
SCHEMBL135028 0.72
SCHEMBL7648163 0.70
SCHEMBL7644924 0.70
SCHEMBL9450629 0.70
SCHEMBL9561983 0.70
SCHEMBL16720251 0.69 CA2 (0.35)
SCHEMBL3338590 0.69 CA2 (0.35)
SCHEMBL18705863 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114751870-B 2- (isoxazole-5-yl) phenyl-3, 4-dihydroxybenzoate and derivative thereof, and synthetic method and application thereof 贵州医科大学 2023-10-20 CN claimed
EP-3262036-B1 THERAPEUTIC PYRIDAZINE COMPOUNDS AND USES THEREOF GENENTECH INC (US) 2023-09-13 EP claimed
EP-4232444-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2023-08-30 EP claimed
CN-114751870-A 2- (isoxazole-5-yl) phenyl-3, 4-dihydroxy benzoate and derivative thereof, and synthesis method and application thereof 贵州医科大学 2022-07-15 CN claimed
WO-2022083569-A1 HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2022-04-28 WO claimed
CN-107531668-B Therapeutic pyridazine compounds and uses thereof 基因泰克公司 2021-10-29 CN claimed
EP-3787747-A1 SMALL MOLECULE DEGRADERS OF POLYBROMO-1 (PBRM1) Dana-Farber Cancer Institute, Inc. (US) 2021-03-10 EP claimed
US-20210038599-A1 SMALL MOLECULE DEGRADERS OF POLYBROMO-1 (PBRM1) DANA-FARBER CANCER INSTITUTE, INC. (US) 2021-02-11 US claimed
EP-3262036-A1 THERAPEUTIC PYRIDAZINE COMPOUNDS AND USES THEREOF Genentech, Inc. (US) 2018-01-03 EP claimed
CN-105130995-B Pyrrolidone compound and its preparation method and application 杭州成邦医药科技有限公司 2017-08-11 CN claimed
WO-2006055184-A2 NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-26 WO claimed
US-20050187217-A1 Compositions useful as inhibitors of voltage-gated ion channels VERTEX PHARMACEUTICALS INCORPORATED 2005-08-25 US claimed
CN-1356988-A Phenoxy fluoropyrimidines BAYER AG (DE) 2002-07-03 CN claimed
US-5707844-A QUINOLINECARBOXYLIC ACID SALTS AS HAPTAN SPECIFIC ANTIBODIES THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-13 US claimed
CN-1150950-A Cephalosporin derivatives HOFFMANN LA ROCHE (CH) 1997-06-04 CN claimed
EP-0761673-A1 Cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 1997-03-12 EP claimed
EP-0702726-A1 IMMUNOASSAY REAGENTS AND METHODS FOR DETECTING BREQUINAR AND ANALOGS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-03-27 EP claimed
US-5393891-A Useful as standards in testing for presence of quinoline carboxylic acids THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-02-28 US claimed
WO-1994029478-A1 IMMUNOASSAY REAGENTS AND METHODS FOR DETECTING BREQUINAR AND ANALOGS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-12-22 WO claimed
US-4226864-A BACTERICIDES, ANTIBIOTICS SHIONOGI & CO., LTD. (JP) 1980-10-07 US claimed